Literature DB >> 25706078

Favipiravir for children with Ebola.

Naïm Bouazza1, Jean-Marc Treluyer2, Frantz Foissac1, France Mentré3, Anne-Marie Taburet4, Jérémie Guedj3, Xavier Anglaret5, Xavier de Lamballerie6, Sakoba Keïta7, Denis Malvy5, Pierre Frange8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25706078     DOI： 10.1016/S0140-6736(15)60232-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

1.  Updates on Treatment of Ebola Virus Disease.

Authors:  Lakshmi Krishnasamy; Chitralekha Saikumar
Journal:  Malays J Med Sci       Date:  2015-11

Review 2.  Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials.

Authors:  Vincent Madelain; Thi Huyen Tram Nguyen; Anaelle Olivo; Xavier de Lamballerie; Jérémie Guedj; Anne-Marie Taburet; France Mentré
Journal:  Clin Pharmacokinet       Date:  2016-08       Impact factor: 6.447

3.  Favipiravir use in children with COVID-19 and acute kidney injury: is it safe?

Authors:  Yasemin Ozsurekci; Pembe Derin Oygar; Sibel Laçinel Gürlevik; Selman Kesici; Seza Ozen; Eda Didem Kurt Sukur; Bora Gülhan; Rezan Topaloglu; Benan Bayrakci; Ali Bülent Cengiz
Journal:  Pediatr Nephrol       Date:  2021-05-22       Impact factor: 3.714

4.  Responding to ever-changing epidemiological dynamics of Ebola virus disease.

Authors:  Yuki Maehira; Yohei Kurosaki; Tomoya Saito; Jiro Yasuda; Masayoshi Tarui; Denis J M Malvy; Tsutomu Takeuchi
Journal:  BMJ Glob Health       Date:  2016-11-24

5.  First Newborn Baby to Receive Experimental Therapies Survives Ebola Virus Disease.

Authors:  Jenny Dörnemann; Chiara Burzio; Axelle Ronsse; Armand Sprecher; Hilde De Clerck; Michel Van Herp; Marie-Claire Kolié; Vesselina Yosifiva; Severine Caluwaerts; Anita K McElroy; Annick Antierens
Journal:  J Infect Dis       Date:  2017-01-15       Impact factor: 5.226

6.  Challenges in preparing and implementing a clinical trial at field level in an Ebola emergency: A case study in Guinea, West Africa.

Authors:  Sara Carazo Perez; Elin Folkesson; Xavier Anglaret; Abdoul-Habib Beavogui; Emmanuel Berbain; Alseny-Modet Camara; Evelyn Depoortere; Annabelle Lefevre; Piet Maes; Kristian Nødtvedt Malme; Jean-Marie Denis Malvy; Sien Ombelet; Geertrui Poelaert; Daouda Sissoko; Alexis Tounkara; Pierre Trbovic; Pascal Piguet; Annick Antierens
Journal:  PLoS Negl Trop Dis       Date:  2017-06-22

7.  Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted.

Authors:  Thi Huyen Tram Nguyen; Jérémie Guedj; Xavier Anglaret; Cédric Laouénan; Vincent Madelain; Anne-Marie Taburet; Sylvain Baize; Daouda Sissoko; Boris Pastorino; Anne Rodallec; Géraldine Piorkowski; Sara Carazo; Mamoudou N Conde; Jean-Luc Gala; Joseph Akoi Bore; Caroline Carbonnelle; Frédéric Jacquot; Hervé Raoul; Denis Malvy; Xavier de Lamballerie; France Mentré
Journal:  PLoS Negl Trop Dis       Date:  2017-02-23

8.  Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.

Authors:  Daouda Sissoko; Cedric Laouenan; Elin Folkesson; Abdoul-Bing M'Lebing; Abdoul-Habib Beavogui; Sylvain Baize; Alseny-Modet Camara; Piet Maes; Susan Shepherd; Christine Danel; Sara Carazo; Mamoudou N Conde; Jean-Luc Gala; Géraldine Colin; Hélène Savini; Joseph Akoi Bore; Frederic Le Marcis; Fara Raymond Koundouno; Frédéric Petitjean; Marie-Claire Lamah; Sandra Diederich; Alexis Tounkara; Geertrui Poelart; Emmanuel Berbain; Jean-Michel Dindart; Sophie Duraffour; Annabelle Lefevre; Tamba Leno; Olivier Peyrouset; Léonid Irenge; N'Famara Bangoura; Romain Palich; Julia Hinzmann; Annette Kraus; Thierno Sadou Barry; Sakoba Berette; André Bongono; Mohamed Seto Camara; Valérie Chanfreau Munoz; Lanciné Doumbouya; Patient Mumbere Kighoma; Fara Roger Koundouno; Cécé Moriba Loua; Vincent Massala; Kinda Moumouni; Célia Provost; Nenefing Samake; Conde Sekou; Abdoulaye Soumah; Isabelle Arnould; Michel Saa Komano; Lina Gustin; Carlotta Berutto; Diarra Camara; Fodé Saydou Camara; Joliene Colpaert; Léontine Delamou; Lena Jansson; Etienne Kourouma; Maurice Loua; Kristian Malme; Emma Manfrin; André Maomou; Adele Milinouno; Sien Ombelet; Aboubacar Youla Sidiboun; Isabelle Verreckt; Pauline Yombouno; Anne Bocquin; Caroline Carbonnelle; Thierry Carmoi; Pierre Frange; Stéphane Mely; Vinh-Kim Nguyen; Delphine Pannetier; Anne-Marie Taburet; Jean-Marc Treluyer; Jacques Kolie; Raoul Moh; Minerva Cervantes Gonzalez; Eeva Kuisma; Britta Liedigk; Didier Ngabo; Martin Rudolf; Ruth Thom; Romy Kerber; Martin Gabriel; Antonino Di Caro; Roman Wölfel; Jamal Badir; Mostafa Bentahir; Yann Deccache; Catherine Dumont; Jean-François Durant; Karim El Bakkouri; Marie Gasasira Uwamahoro; Benjamin Smits; Nora Toufik; Stéphane Van Cauwenberghe; Khaled Ezzedine; Eric D'Ortenzio; Eric Dortenzio; Louis Pizarro; Aurélie Etienne; Jérémie Guedj; Alexandra Fizet; Eric Barte de Sainte Fare; Bernadette Murgue; Tuan Tran-Minh; Christophe Rapp; Pascal Piguet; Marc Poncin; Bertrand Draguez; Thierry Allaford Duverger; Solenne Barbe; Guillaume Baret; Isabelle Defourny; Miles Carroll; Hervé Raoul; Augustin Augier; Serge P Eholie; Yazdan Yazdanpanah; Claire Levy-Marchal; Annick Antierrens; Michel Van Herp; Stephan Günther; Xavier de Lamballerie; Sakoba Keïta; France Mentre; Xavier Anglaret; Denis Malvy
Journal:  PLoS Med       Date:  2016-03-01       Impact factor: 11.069

9.  Drugs being investigated for children with COVID-19.

Authors:  Melis Deniz; Anıl Tapısız; Hasan Tezer
Journal:  Acta Paediatr       Date:  2020-06-22       Impact factor: 4.056

Review 10.  Modeling Favipiravir Antiviral Efficacy Against Emerging Viruses: From Animal Studies to Clinical Trials.

Authors:  Vincent Madelain; France Mentré; Sylvain Baize; Xavier Anglaret; Cédric Laouénan; Lisa Oestereich; Thi Huyen Tram Nguyen; Denis Malvy; Géraldine Piorkowski; Frederik Graw; Stephan Günther; Hervé Raoul; Xavier de Lamballerie; Jérémie Guedj
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2020-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.